LTGO · Forms 3, 4, 5
Insider trades at Latigo Biotherapeutics, Inc.
2 insiders bought $5M of Latigo Biotherapeutics, Inc. stock on the open market in the last 90 days.
Every Form 3, 4 and 5 filed for Latigo Biotherapeutics, Inc. (LTGO) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Sanofi | 10% owner | Became an insider (Form 3) | Form 3 | ||||
| 5AM Ventures VI, L.P. | 10% owner | Conversion | 4,975,543 | Form 4 | |||
| 5AM Ventures VI, L.P. | 10% owner | Conversion | 2,350,419 | Form 4 | |||
| Sanofi | 10% owner | Conversion | 494,800 | Form 4 | |||
| Sanofi | 10% owner | Conversion | 177,978 | Form 4 | |||
| Westlake BioPartners Fund I, L.P. | 10% owner | Conversion | 938,979 | Form 4 | |||
| Westlake BioPartners Fund I, L.P. | 10% owner | Conversion | 3,547,842 | Form 4 | |||
| Westlake BioPartners Fund I, L.P. | 10% owner | Conversion | 1,027,635 | Form 4 | |||
| Westlake BioPartners Fund I, L.P. | 10% owner | Conversion | 3,464,072 | Form 4 | |||
| Westlake BioPartners Fund I, L.P. | 10% owner | Conversion | 1,484,401 | Form 4 | |||
| Westlake BioPartners Fund I, L.P. | 10% owner | Conversion | 165,519 | Form 4 | |||
| Westlake BioPartners Fund I, L.P. | 10% owner | Conversion | 2,066,857 | Form 4 | |||
| Foresite Capital Management V, LLC | 10% owner | Conversion | 3,117,664 | Form 4 | |||
| Foresite Capital Management V, LLC | 10% owner | Conversion | 445,320 | Form 4 | |||
| Foresite Capital Management V, LLC | 10% owner | Conversion | 1,125,823 | Form 4 | |||
| Foresite Capital Management V, LLC | 10% owner | Conversion | 742,201 | Form 4 | |||
| Foresite Capital Management V, LLC | 10% owner | Buy | 140,000 | $18.00 | $2.5M | Form 4 | |
| Foresite Capital Management V, LLC | 10% owner | Conversion | 195,776 | Form 4 | |||
| Foresite Capital Management V, LLC | 10% owner | Conversion | 3,117,664 | Form 4 | |||
| Foresite Capital Management V, LLC | 10% owner | Conversion | 296,880 | Form 4 | |||
| Todd N Smith | Director | Options or other derivatives | Form 4 | ||||
| James B. Tananbaum | Director | Conversion | 3,117,664 | Form 4 | |||
| James B. Tananbaum | Director | Conversion | 445,320 | Form 4 | |||
| James B. Tananbaum | Director | Conversion | 1,125,823 | Form 4 | |||
| James B. Tananbaum | Director | Conversion | 742,201 | Form 4 | |||
| James B. Tananbaum | Director | Buy | 140,000 | $18.00 | $2.5M | Form 4 | |
| James B. Tananbaum | Director | Conversion | 195,776 | Form 4 | |||
| James B. Tananbaum | Director | Conversion | 3,117,664 | Form 4 | |||
| James B. Tananbaum | Director | Conversion | 296,880 | Form 4 | |||
| Beth C Seidenberg | Director | Conversion | 938,979 | Form 4 | |||
| Beth C Seidenberg | Director | Conversion | 3,547,842 | Form 4 | |||
| Beth C Seidenberg | Director | Conversion | 1,027,635 | Form 4 | |||
| Beth C Seidenberg | Director | Conversion | 3,464,072 | Form 4 | |||
| Beth C Seidenberg | Director | Conversion | 1,484,401 | Form 4 | |||
| Beth C Seidenberg | Director | Conversion | 165,519 | Form 4 | |||
| Beth C Seidenberg | Director | Conversion | 2,066,857 | Form 4 | |||
| Foresite Capital Management V, LLC | 10% owner | Became an insider (Form 3) | Form 3 | ||||
| 5AM Ventures VI, L.P. | 10% owner | Became an insider (Form 3) | Form 3 | ||||
| Westlake BioPartners Fund I, L.P. | 10% owner | Became an insider (Form 3) | Form 3 | ||||
| Kevin Raidy | Director | Became an insider (Form 3) | Form 3 | ||||
| Timothy P Walbert | Director | Became an insider (Form 3) | Form 3 | ||||
| Neha Krishnamohan | CFO and Chief Business Officer | Became an insider (Form 3) | Form 3 | ||||
| Todd N Smith | Director | Became an insider (Form 3) | Form 3 | ||||
| Sara Bonstein | Director | Became an insider (Form 3) | Form 3 | ||||
| Neil Singla | Chief Medical Officer | Became an insider (Form 3) | Form 3 | ||||
| Nima Farzan | President and CEO | Became an insider (Form 3) | Form 3 | ||||
| James B. Tananbaum | Director | Became an insider (Form 3) | Form 3 | ||||
| Beth C Seidenberg | Director | Became an insider (Form 3) | Form 3 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.